BaCkground uncontrolled hypertension is a common and important risk factor for heart disease and stroke. Nevertheless, the control rate among patients taking prescribed medication and/or therapeutic lifestyle modification has remained about the same for the past several decades.
Hypertension affects nearly one-third of the adult population in the United States, 1 and is associated with higher risk for coronary artery disease, cerebrovascular disease, and kidney disease. 2 Many of these complications can be prevented with appropriate hypertension control. 2, 3 Despite the therapeutic lifestyle modifications and the availability of multiple antihypertensive agents that successfully control hypertension, studies indicate that as many as two-thirds of those with hypertension in the United States are either untreated or undertreated. For example, only 58% of adults with hypertension received antihypertensive medication in 1999-2000 and just half of these achieved hypertension control (blood pressure <140/90 mm Hg). 4 Physician offices are the major source for prescribing antihypertensive therapy. Indeed, hypertension is the most frequently recorded principal diagnosis for ambulatory visits to physician offices in the United States. 5 Using recent data from the National Ambulatory Medical Care Survey (NAMCS), we assessed characteristics associated with hypertension control among patients who made hypertension-related office visits in the United States.
methodS
Data. This study used data from the NAMCS, a national crosssectional survey of physicians that collects information on medical visits in physician office settings. 6 NAMCS surveys have been conducted annually since 1973 by the US National Center for Health Statistics. NAMCS participants included both primary care physicians and specialists providing direct patient care in office-based settings. Practices that were eligible for sampling included those of all office-based physicians listed in the American Medical Association or American Osteopathic Association master files who were principally involved in patient care and who were not federal employees. Specialty designations in these master files are reported by the physicians, including general and family practice, internal medicine, pediatrics, cardiology, and others including nephrology. Our analyses used data from 2003 and 2004 NAMCS surveys, which were aggregated to yield sufficient sample sizes for a cross-sectional analysis of the most recent hypertension-related office visits of the United States. 6 NAMCS used a multistage probability sampling design including probability sampling of defined geographic areas, The information collected during each visit includes demographic and clinical characteristics related to the visit. All information was transcribed by the managing physician or the physician's clinical staff onto a standard visit record form. Information regarding the clinical practice setting was obtained through personal interviews with participating physicians conducted by the US Census Bureau, on behalf of the National Center for Health Statistics.
Text entries for physician diagnoses were made by the survey respondent. These text entries for the diagnoses were then classified and coded to the ICD-9-CM by contracted medical coders as part of the data processing.
Study population and measurements. All hypertension-related visits were identified by any ICD-9-CM code for hypertension (401-405) from up to three physician diagnoses or by "reason for visits" listed as "hypertension. "
The following measurements were included in this report: age, gender, race (non-Hispanic white, non-Hispanic black, Hispanics, and others), major source of payment for this visit (private insurance, government insurance, others, and no insurance), region (Northeast, Midwest, South, and West) and whether the office was located at a metropolitan statistical area. Clinical characteristics for each visit included blood pressure measurement during the visits, whether the patient was referred for this visit, and whether this visit was the initial visit to this physician; whether a follow-up visit was scheduled; up to three patients' reasons for this visit; and any diagnostic tests ordered by the physician during the visit such as urinalysis, hemoglobin, blood lipid, blood glucose, HgbA1c, electrocardiogram and X-ray. Physician practice information included specialty (general/family practitioner, internist, cardiologist, or other) and whether the physician was the patient's primary care physician. Other risk factors included hyperlipidemia (defined by ICD-9-CM 272 or reason for visit with "high cholesterol"), obesity (defined by ICD-9-CM 278 or reason for visit with "weight gain"), smoking (identified by checking "current tobacco use" or reason for visit with "smoking problems"). In addition, visits with comorbid conditions of diabetes (ICD-9-CM 250), coronary heart disease (ICD-9-CM 410-414), heart failure (ICD-9-CM 428), and renal diseases (ICD-9-CM 580-589) were identified. Hypertension-related visits were then classified by measured blood pressure level as either controlled hypertension (systolic blood pressure <140 and diastolic blood pressure <90 mm Hg) or uncontrolled hypertension (systolic blood pressure ≥140 or diastolic blood pressure ≥90 mm Hg). Additional cut-points of blood pressure control at 130/80 mm Hg (systolic blood pressure <130 and diastolic blood pressure <80) and 145/95 mm Hg (systolic blood pressure <145 and diastolic blood pressure <95) were included for comparison.
We identified counseling/education (dietary/nutrition, exercise, stress management, smoking cessation or weight reduction) as behavior and lifestyle modification for hypertension management. Any visit which included counseling/ education during the visit or referred the patient to any one of these counseling/education services was considered as providing lifestyle modification. In addition, NAMCS allows for reporting up to eight medications provided during the visits, which included medications prescribed during the current visit and/or medications prescribed during previous visits and were asked to take continuously. Individual codes (generic and brand) of all antihypertensive medications were categorized to specific classes as diuretics, calcium channel blockers, β-blockers, α-blockers, and angiotensin-converting enzyme inhibitors (including angiotensin receptor blockers). We estimated the percentage of visits at which medications within the specific classes of hypertensive medication were provided, prescribed, or continued, as well as any combination of antihypertensive medicines were provided. For type of hypertension management, we categorized hypertension-related visits as no treatment, lifestyle modification only, antihypertensive therapy only, and both lifestyle modification and antihypertensive medication therapy.
Statistical analysis. Selected demographic and clinical characteristics were compared between hypertensive controlled and uncontrolled groups using two sample t-tests for continuous variables and chi-square tests for discrete variables. For variables showing significantly different distribution between the two groups, further blood pressure control rates for each category were presented for blood pressure controlled at different cut-points: <130/80 mm Hg, <140/90 mm Hg and <145/95 mm Hg. Multivariate logistic regression analysis was used to examine the associations of demographic or clinical characteristics with the likelihood of hypertension control and to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of hypertension control. To account for the complex sample design of NAMCS, data were analyzed with SUDAAN (RTI, Research Triangle Park, NC). To comply with National Center for Health Statistics reliability standards, all estimates were based on at least 30 sample records and estimates with a relative s.e. (s.e. divided by the estimate) <30%. 6 
reSultS

During 2003 and 2004
, an estimated 1,817 million visits (95% CI = 1,805-1,829 million) were made to physicians' offices in the United States. Of these, 175,538,000 (9.7%, 95% CI = 9.3-10.1%) were hypertension-related visits. Among hypertension-related visits, an estimated 164,701,000 (94.0%) had blood pressure measured. Subsequent analyses were restricted to data from these visits. The mean age of patients seen at hypertension-related visits was 62.8 years (95% CI articles Hypertension Control at Physicians' Offices 62.0-63.6) and 58% of visits were made by female patients. The mean systolic blood pressure was 140 mm Hg (95% CI 138-141) and mean diastolic blood pressure was 81 mm Hg (95% CI 80-82). Overall, 44.3% (95% CI = 42.1-46.5%) of hypertension-related visits had a blood pressure <140/90 mm Hg. After eliminating 16.8% of visits that were considered an initial visit, the overall hypertension control rate was 45.6% (95% CI = 43.2-48.0%). In addition, there were 17.3% and 62.3% visits with blood pressure <130/80 mm Hg and 145/95 mm Hg respectively.
In comparison to those who made visits with uncontrolled hypertension, those with controlled hypertension were older and more likely to have diabetes, coronary heart disease, and hyperlipidemia. In addition, their hypertension was less likely to be the first-listed diagnosis ( Table 1) . Visits with controlled hypertension were less likely to visit their physician initially and more likely to visit their primary care physician than nonprimary care physician and their physicians were more likely to be internists or cardiologists rather than general or family physicians. Visits with blood pressure >140/90 mm Hg were more likely to get antihypertensive drugs than those whose blood pressure were controlled. However, no difference was noted for using specific antihypertensive drugs.
Percentages of blood pressure control at different blood pressure levels by patient characteristics (Table 2) showed that the control rate in office visits was significantly lower among patients with hypertension as the first-listed diagnosis ( Table 2) . Visits among patients with coronary heart disease, diabetes, and hyperlipidemia were more likely to have blood pressure control than those without. In addition, visits with primary care physicians and with internists or cardiologists were more likely to be associated with controlled hypertension than non-primary care physicians and general or family physicians, respectively. On the other hand, hypertension was less likely to be controlled if the visit was an initial visit or the patient was referred from another physician. Patients who received antihypertensive drug treatment during the visits were more likely to have uncontrolled blood pressure. No difference in hypertension control rates in office visit was observed by age, race, insurance status, heart failure, renal disease, obesity, smoking status, and type of antihypertensive medication (data not shown here). Of note, only 22.4% (s.e. Values are either mean ± s.d. or % (s.e.), in the latter case s.e. is given in parentheses. ACE, angiotensin-converting enzyme; BP, blood pressure; CHD, coronary heart disease; DBP, diastolic blood pressure; HF, heart failure; MSA, metropolitan statistical area; SBP, systolic blood pressure. 2 Multivariate logistic regression model was conducted to determine the association of patient characteristics and blood pressure control at different levels ( Table 3 ). All characteristics with P value of 0.1 or less at univariate analysis were included in multivariate logistical regression models. The likelihood of blood pressure control was associated with a diagnosis of coronary heart disease, a visit to a primary care physician as opposed to non-primary care physician, and visits to internists or cardiologists rather than to family physicians. Visits among patients with diabetes were more likely to have blood pressure <130/80 mm Hg, but not other blood pressure cut-points. Visits among patients with hypertension as the first diagnosis were less likely to have hypertension controlled than those with hypertension as the secondary diagnosis. Visits provided with antihypertensive drugs were less likely to have blood pressure controlled.
diSCuSSion
In 2003 and 2004, less than half of those who made hypertension-related physician office visits in the United States achieved blood pressure <140/90 mm Hg. This is consistent with national survey data 4 and reflects the challenge facing patients who are aware of their hypertension and are seeking to control blood pressure. Previous studies based on different patient populations, such as nationally representative samples, innercity communities, and health-care organizations, revealed that hypertension control estimates in the United States were generally low, ranging from 20 to 43%. [7] [8] [9] [10] [11] [12] [13] This is the first report on hypertension control that is based on data from a national survey of physician office visits. articles
Hypertension Control at Physicians' Offices
In contrast to findings from National Health and Nutritional Examination Survey showing that hypertension control among patients was related to access to health care and sociodemographic characteristics, 10 in this study the actual attainment of hypertension control in physician office visits was not related to patients' sociodemographic characteristics. Since all samples in this report were based on physician office visits, patients here already had access to health care. Interestingly, blood pressure control status in office visits was associated with existing comorbidity of coronary heart disease, hyperlipidemia, or hypertension identified as the primary cause for the office visit, not an initial visit to the physician, as well as physicians' specialty. As both blood pressure level and treatment provided were measured during the current visits, we were unable to conclude whether the treatment was effective in controlling blood pressure. Instead, our finding did suggest that visits with poor blood pressure control were more likely to receive antihypertensive drug treatment during the visits.
The impact of comorbidity on hypertension control during office visits has not been examined extensively. We found that existing coronary heart disease and hyperlipidemia were associated with better hypertension control. This may be because of the improved compliance of antihypertensive therapy in these patients or more aggressive hypertension management for patients with these conditions owing to increased risk of myocardial infarction. 14 While JNC VII recommends blood pressure levels <130/80 mm Hg for diabetes patients, 2 <23% of visits with diabetes reached this goal. However, results here indicated that diabetes visits were 49% more likely to have blood pressure <130/80 mm Hg as compared with visits without diabetes-suggesting that effort had been made to control blood pressure more aggressively among those with diabetes.
Patient noncompliance contributes to poor hypertension control. 15 Although these data did not include measurement of compliance, the findings that hypertension control rate was higher among visits to their primary care physician and among visits that were not an initial visit to the physician suggest that patients who regularly visit their physician are more likely to achieve hypertension control.
Patients visiting internists or cardiologists were more likely to have hypertension control than those visiting general or family practitioners. A study of physicians' knowledge and practice of prescribed medication for hypertension showed that compared with general and family practitioners, cardiologists were more aware of JNC VII guidelines, including knowledge of indications and contraindications for antihypertensive medications, attitudes toward blood pressure assessment, and management goals. 16 Although cardiologists may have a higher likelihood of achieving blood pressure control, more hypertensive patients are treated by general or family practitioners, as well as by nurse practitioners. In a national survey of 316 primary care physicians, 41% were unfamiliar with current JNC guidelines, and 43% would not 17 Nevertheless, the fact that only about 20% of hypertension-related visits in the United States were taking diuretics even though diuretics were listed as the first-line drug for hypertension by JNC VII guidelines suggests that increased implementation of guidelines for hypertension control is critically needed. The low hypertension control rate in the United States suggests that a substantial number of future cardiovascular events may not be prevented. [18] [19] [20] Although impediments to hypertension control include lack of awareness and failure to start or remain on prescribed antihypertensive medication(s) or in therapeutic lifestyle modifications, 2, 21 clinical trials have revealed that higher control rates were achievable. For example, in the Antihypertensive and lipid-lowering Treatment to Prevent Heart Attack Trial, 55% of participants in the three treatment arms had their hypertension controlled (<140/90 mm Hg) at the first annual visit, and 66% of patients were at this target 4 years later. 22 Moreover, in the Controlled Onset Verapamil Investigation of Cardiovascular End Points Trial, 85% of hypertensive patients were controlled (<140/ 90 mm Hg) at the end of the titration period, and control rates exceeded 60% throughout the trial. 23 Although the control rates from randomized trials cannot be directly compared with those from clinical practice, randomized data showed the feasibility of achieving the blood pressure target of 68% as recommended by Healthy People 2010. 24 Since in both of the trials mentioned above, care was delivered predominantly by general or family physicians rather than specialists, 25 blood pressure control should be achievable in population receiving standard medical care.
There are some limitations regarding NAMCS data. First, the cross-sectional nature of the data does not allow specific patients to be followed longitudinally. The lack of the previous treatment history prevented us from assessing the effectiveness of blood pressure control by different antihypertensive drugs. Second, the unit of analysis was the visit, rather than the patient. While hypertension control rates by visit would not be the same as measured by patient, an earlier longitudinal study showed that in hypertension clinical care, the number of visits was not related to hypertension control, and control rates determined based on visits and patients were comparable. 26 Third, NAMCS data included only three diagnostic codes and eight prescribed medications. Thus, it may be possible that some visits with hypertension may be excluded if they have more than three other important diagnoses. It is also possible that antihypertensive drugs would be omitted in patients treated with more than eight drugs. Fourth, blood pressure was routinely measured during office visits. lastly, the data did not provide information about the reasons that patients were not taking antihypertensive medications, such as adverse medication reactions or patient preference. Nevertheless, the NAMCS provides distinctive and unique information about hypertension-related physician office visits in the United States. The large sample size and national representation of the data provides a degree of detail of clinical services not available from insurance claims or other sources. The results of this study documents the overall hypertension control rates among patients during hypertension-related visits.
This study provides further evidence that, in the United States, <50% of hypertension-related physician office visits had hypertension under control. New strategies for systems and policy change which assist physicians to improve clinical management of hypertension are needed.
